亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

An Liquid Chromatography–Tandem Mass Spectrometry Method for the Simultaneous Determination of Afatinib, Alectinib, Ceritinib, Crizotinib, Dacomitinib, Erlotinib, Gefitinib, and Osimertinib in Human Serum

阿法替尼 埃罗替尼 奥西默替尼 克里唑蒂尼 阿列克替尼 铈替尼 间变性淋巴瘤激酶 吉非替尼 化学 治疗药物监测 盐酸厄洛替尼 表皮生长因子受体 色谱法 药理学 医学 药品 肺癌 肿瘤科 生物化学 恶性胸腔积液 受体
作者
Yuji Mukai,Azusa Wakamoto,Tae Hatsuyama,Tatsunari Yoshida,Hideki Sato,Akihisa Fujita,Nobuo Inotsume,Takaki Toda
出处
期刊:Therapeutic Drug Monitoring [Lippincott Williams & Wilkins]
卷期号:43 (6): 772-779 被引量:14
标识
DOI:10.1097/ftd.0000000000000895
摘要

Routine therapeutic drug monitoring is a promising approach for the rational use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and anaplastic lymphoma kinase (ALK) inhibitors. The purpose of this study was to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of 5 EGFR-TKIs (afatinib, dacomitinib, erlotinib, gefitinib, and osimertinib) and 3 ALK inhibitors (alectinib, ceritinib, and crizotinib).A 100-mL aliquot of serum was diluted with 100 μL of 1% aqueous ammonia containing internal standards and then purified using the supported liquid extraction method. LC-MS/MS was conducted in positive ionization mode, and the method was validated according to published guidelines.Calibration curves were linear across concentration ranges examined. The intra- and interassay accuracies were 90.7%-110.7% and 94.7%-107.6%, respectively. All intra- and interassay imprecision values were ≤10.1%. The EGFR-TKIs and ALK inhibitors examined in this study, except osimertinib, which could be stored on ice for at least 5 hours, were stable at room temperature for 3 hours. For the internal standard-normalized matrix factors, the mean recovery and percent coefficient of variation values ranged between 54%-112% and 1.7%-11.7%, respectively. This method successfully determined serum concentrations of afatinib, alectinib, erlotinib, gefitinib, and osimertinib in clinical samples. Serum levels of kinase inhibitors consistently reflected those reported in previous studies.An LC-MS/MS method suitable for the simultaneous determination of 5 EGFR-TKIs and 3 ALK inhibitors in serum was developed and validated. The newly developed method enabled the determination of 5 of 8 target drugs examined in clinical samples. However, a large number of clinical samples need to be analyzed to verify the usefulness of the method.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
好的发布了新的文献求助10
1秒前
无奈的琦完成签到,获得积分10
1秒前
GingerF应助anugraphics采纳,获得100
3秒前
4秒前
Kao应助科研通管家采纳,获得10
8秒前
科目三应助科研通管家采纳,获得10
8秒前
Kao应助科研通管家采纳,获得10
8秒前
Kao应助科研通管家采纳,获得10
8秒前
科研通AI6.2应助陈奕宏采纳,获得10
9秒前
10秒前
阳光萝完成签到,获得积分10
14秒前
田大明发布了新的文献求助10
16秒前
科研通AI6.2应助Jenny采纳,获得10
18秒前
CodeCraft应助整齐成仁采纳,获得10
20秒前
秋风应助好的采纳,获得10
29秒前
小二郎应助海洋球采纳,获得10
32秒前
羊羊完成签到,获得积分10
37秒前
40秒前
42秒前
海洋球发布了新的文献求助10
44秒前
真实的瑾瑜完成签到 ,获得积分10
46秒前
陈奕宏发布了新的文献求助10
48秒前
顾白凡完成签到,获得积分0
51秒前
顺心安雁完成签到,获得积分10
1分钟前
笑点低的惊蛰完成签到,获得积分20
1分钟前
1分钟前
1分钟前
香蕉觅云应助灵巧绿海采纳,获得10
1分钟前
1分钟前
1分钟前
LELE完成签到 ,获得积分0
1分钟前
1分钟前
Jenny发布了新的文献求助10
1分钟前
1分钟前
整齐成仁发布了新的文献求助10
1分钟前
可爱惠完成签到,获得积分10
1分钟前
灵巧绿海发布了新的文献求助10
1分钟前
犹豫擎苍完成签到,获得积分10
1分钟前
ding应助整齐成仁采纳,获得10
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
A Case Study on Hotels as Noncongregate Emergency Living Accommodations for Returning Citizens 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7765626
求助须知:如何正确求助?哪些是违规求助? 9309838
关于积分的说明 20312686
捐赠科研通 7350386
什么是DOI,文献DOI怎么找? 3314941
关于科研通互助平台的介绍 2464368
邀请新用户注册赠送积分活动 2329411